Annual report
9341.TEDINET S100W2S5
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥8.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥6.5bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥804m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥686m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥629m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥8.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥8.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥5.4bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.8bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.0bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥777m | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥624m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥276m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥94m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥113m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥179m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥68m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥377m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥60m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥75m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥79.78 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.35 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.61 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.96 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.88 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥79.02 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥96.5 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.07 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥378.77 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥324.82 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥229.47 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥91.9 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥48.67 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.6% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 22.9% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 35.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 45.6% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 60.9% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 138.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 408 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 352 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 294 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 242 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 185 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥9.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥8.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥6.4bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥774m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.7bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥666m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥605m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥8.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥5.3bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.7bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥2.1bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥6.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.4bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥738m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥80.71 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥96 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.52 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.72 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.35 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥79.94 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥95.16 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥72.03 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥374.86 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥320.1 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥225.51 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥88.65 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥46.76 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.8% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.7% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 23.5% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 35.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 46.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 61.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 139.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,806,600 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,794,100 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,598,100 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 80,900 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,890 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 378 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 322 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 269 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 215 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 159 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 35 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥565m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥565m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥122m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥113m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥10m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥21m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥6.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Medical Platform Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥75m |
| Medical Platform Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥34m |
| Medical Platform Businessreportable segment | employees | at 2025-03-31 | 230 pure |
| Medical Platform Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.3bn |
| Medical Platform Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.3bn |
| Medical Platform Businessreportable segment | segment assets | at 2025-03-31 | ¥1.2bn |
| Medical Platform Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥3.1bn |
| Smart Clinic Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥38m |
| Smart Clinic Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥23m |
| Smart Clinic Businessreportable segment | employees | at 2025-03-31 | 89 pure |
| Smart Clinic Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Smart Clinic Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Smart Clinic Businessreportable segment | segment assets | at 2025-03-31 | ¥796m |
| Smart Clinic Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥579m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥113m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥57m |
| —segment total | employees | at 2025-03-31 | 319 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥9.4bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥9.4bn |
| —segment total | segment assets | at 2025-03-31 | ¥2.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥119m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥59m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥10.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥10.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥585m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥585m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥150m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥173m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥12m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥16m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥6.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥1.5bn |
| Medical Platform Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥31m |
| Medical Platform Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥33m |
| Medical Platform Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Platform Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Platform Businessreportable segment | segment assets | at 2024-03-31 | ¥1.0bn |
| Medical Platform Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Smart Clinic Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥22m |
| Smart Clinic Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥21m |
| Smart Clinic Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Smart Clinic Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Smart Clinic Businessreportable segment | segment assets | at 2024-03-31 | ¥741m |
| Smart Clinic Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥680m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥53m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥55m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.1bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.1bn |
| —segment total | segment assets | at 2024-03-31 | ¥1.8bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥56m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥58m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 15 pure |
| Medical Platform Businessreportable segment | employees | at 2025-03-31 | 228 pure |
| Smart Clinic Businessreportable segment | employees | at 2025-03-31 | 81 pure |
| —segment total | employees | at 2025-03-31 | 309 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,392
| Item | Context | Value | Unit |
|---|---|---|---|
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)平瀬 智樹 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)東京都渋谷区 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)株式会社平瀬商店 | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)東京都渋谷区猿楽町16-11 | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)東京都港区赤坂一丁目8-1 | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)内藤 信至 | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)東京都渋谷区 | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)青山 圭秀 | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)広島県尾道市 | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)上田八木短資株式会社 | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)大阪府大阪市中央区高麗橋二丁目4-2 | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)木下 圭一郎 | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)東京都千代田区 | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)SCBHK AC LIECHTENSTEINISCHE LANDESBANK AG（常任代理人 株式会社三菱UFJ銀行） | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)STAEDTLE 44, 9490 VADUZ, LIECHTENSTEIN（東京都千代田区丸の内一丁目4番5号） | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)提橋 由幾 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は100株であります。 | |
| Description issued shares voting rights | CurrentYearInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)株式会社GENOVA | |
| Address of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)東京都渋谷区２丁目21番1号 | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Date of resolution dividends of surplus | FilingDateInstant_Row1Member | 2025-06-25 | |
| Resolution dividends of surplus | FilingDateInstant_Row1Member | Original text (Japanese)定時株主総会決議（予定） | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |